Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9514)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through May 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | She WH, Chok KS. Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol 2015; 7(18): 2147-2154 [PMID: 26328026 DOI: 10.4254/wjh.v7.i18.2147] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i18/2147.htm |
| Number | Citing Articles |
| 1 |
Riccardo Carloni, Simone Sabbioni, Alessandro Rizzo, Angela Dalia Ricci, Andrea Palloni, Cataldo Petrarota, Antonio Cusmai, Simona Tavolari, Gennaro Gadaleta-Caldarola, Giovanni Brandi. Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1445 doi: 10.2147/JHC.S390963
|
| 2 |
Allison N. Devitt, Abigail L. Vargas, Wei Zhu, Benjamin James Des Soye, Fatma Ayaloglu Butun, Tyler Alt, Nicholas Kaley, Glaucio M. Ferreira, Graham R. Moran, Neil L. Kelleher, Dali Liu, Richard B. Silverman. Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase. ACS Chemical Biology 2024; 19(5): 1066 doi: 10.1021/acschembio.4c00022
|
| 3 |
Paula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, Fabian Weykamp, Katharina Seidensaal, Christoph Springfeld, Michael T. Dill, Thomas Longerich, Peter Schirmacher, Arianeb Mehrabi, René Michael Mathy, Bruno C. Köhler, Jürgen Debus, Klaus Herfarth, Jakob Liermann. Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer. Radiation Oncology 2025; 20(1) doi: 10.1186/s13014-025-02594-y
|
| 4 |
Francisco Tustumi, Lucas Ernani, Fabricio F. Coelho, Wanderley M. Bernardo, Sérgio S. Junior, Jaime A.P. Kruger, Gilton M. Fonseca, Vagner B. Jeismann, Ivan Cecconello, Paulo Herman. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis. HPB 2018; 20(12): 1109 doi: 10.1016/j.hpb.2018.06.1798
|
| 5 |
Richard X. Sousa Da Silva, Beat Muellhaupt, Philipp Dutkowski, Pierre-Alain Clavien. Liver transplantation for malignant liver tumors. iLIVER 2022; 1(1): 3 doi: 10.1016/j.iliver.2022.04.002
|
| 6 |
Valtteri Kairaluoma, Niko Kemi, Vesa-Matti Pohjanen, Juha Saarnio, Olli Helminen. Tumour budding and tumour–stroma ratio in hepatocellular carcinoma. British Journal of Cancer 2020; 123(1): 38 doi: 10.1038/s41416-020-0847-1
|
| 7 |
Valtteri KAIRALUOMA, Mira KARJALAINEN, Vesa-Matti POHJANEN, Juha SAARNIO, Jarmo NIEMELÄ, Heikki HUHTA, Olli HELMINEN. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 years. Minerva Surgery 2021; 76(3) doi: 10.23736/S2724-5691.21.08426-1
|
| 8 |
Jan L. van der Hoek, Tess J. Snoeijink, Hadi Mirgolbabaee, Romaine Kunst, Michel Versluis, Jutta Arens, Srirang Manohar, Erik Groot Jebbink. Ultrasound contrast microbubbles to predict the microsphere distribution during transarterial radioembolization with holmium microspheres, an in vitro proof of concept study. Drug Delivery 2025; 32(1) doi: 10.1080/10717544.2025.2505007
|
| 9 |
Jeffrey Sum-Lung Wong, Yawen Dong, Vikki Tang, Thomas Leung, Cynthia S. Y. Yeung, Anna Tai, Ada Law, Tracy Shum, Gerry Gin-Wai Kwok, Bryan Cho-Wing Li, Roland Leung, Joanne Chiu, Ka-Wing Ma, Wong-Hoi She, Josephine Tsang, Tan-To Cheung, Thomas Yau. The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study. Cancers 2021; 13(9): 2002 doi: 10.3390/cancers13092002
|
| 10 |
Ze-Feng Zhang, Yu-Jun Luo, Quan Lu, Shi-Xue Dai, Wei-Hong Sha. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?. World Journal of Clinical Cases 2018; 6(9): 259-273 doi: 10.12998/wjcc.v6.i9.259
|
| 11 |
Jiye Fan, Liying Tian, Shuhong Huang, Jing Zhang, Baohua Zhao. <p>Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway</p>. OncoTargets and Therapy 2020; : 5407 doi: 10.2147/OTT.S222895
|
| 12 |
Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico, Andrea Palloni, Mariacristina Di Marco, Gennaro Gadaleta-Caldarola, Giovanni Brandi. Dual Immune Checkpoint Blockade in Hepatocellular Carcinoma: Where do we Stand?. Future Oncology 2022; 18(8): 1023 doi: 10.2217/fon-2021-0905
|
| 13 |
JIN-YAN ZHANG, MING-ZHE WENG, FANG-BIN SONG, YONG-GANG XU, QI LIU, JUN-YI WU, JUN QIN, TAO JIN, JUN-MING XU. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. International Journal of Oncology 2016; 48(4): 1590 doi: 10.3892/ijo.2016.3385
|
| 14 |
Bin Li, Yan Zhu, Lei Xie, Shuyang Hu, Shupeng Liu, Xiaoqing Jiang. Portal vein ligation alters coding and noncoding gene expression in rat livers. Biochemistry and Cell Biology 2018; 96(1): 1 doi: 10.1139/bcb-2017-0070
|
| 15 |
Daolin Ji, Xiangyu Zhong, Xingming Jiang, Kaiming Leng, Yi Xu, Zhenglong Li, Lining Huang, Jinglin Li, Yunfu Cui. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathology - Research and Practice 2018; 214(10): 1524 doi: 10.1016/j.prp.2018.08.014
|
| 16 |
Mohamedraed Elshami, Fasih Ali Ahmed, Jonathan J. Hue, Hanna Kakish, Richard S. Hoehn, Luke D. Rothermel, David Bajor, Amr Mohamed, J. Eva Selfridge, John B. Ammori, Jeffrey M. Hardacre, Jordan M. Winter, Lee M. Ocuin. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies. Surgery 2023; 173(2): 289 doi: 10.1016/j.surg.2022.10.011
|
| 17 |
Diamantis I. Tsilimigras, Fabio Bagante, Dimitrios Moris, J. Madison Hyer, Kota Sahara, Anghela Z. Paredes, Rittal Mehta, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. Annals of Surgical Oncology 2020; 27(7): 2321 doi: 10.1245/s10434-020-08452-3
|
| 18 |
Adeel S. Khan, Sandra Garcia-Aroz, Mohammad A. Ansari, Syed M. Atiq, Michael Senter-Zapata, Kathryn Fowler, M.B. Doyle, W.C. Chapman. Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review. International Journal of Surgery 2018; 52: 74 doi: 10.1016/j.ijsu.2018.01.042
|
| 19 |
Shanshan Wang, Jiarui Xie, Xuanxuan Zou, Taotao Pan, Qichao Yu, Zhenkun Zhuang, Yu Zhong, Xin Zhao, Zifei Wang, Rui Li, Ying Lei, Jianhua Yin, Yue Yuan, Xiaoyu Wei, Longqi Liu, Shiping Liu, Huanming Yang, Liang Wu. Single-cell multiomics reveals heterogeneous cell states linked to metastatic potential in liver cancer cell lines. iScience 2022; 25(3): 103857 doi: 10.1016/j.isci.2022.103857
|
| 20 |
Qinqin Liu, Nan You, Jing Li, Ke Wu, Xuehui Peng, Zheng Wang, Liang Wang, Yinan Zhu, Lu Zheng. Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.694409
|
| 21 |
Josephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Bryan Cho Wing Li, Roland Leung, Joanne Chiu, Tan to Cheung, Thomas Yau. Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib. Expert Review of Gastroenterology & Hepatology 2021; 15(6): 589 doi: 10.1080/17474124.2021.1899808
|
| 22 |
Josep Marti, Massimo Giacca, Kutaiba Alshebeeb, Sumeet Bahl, Charles Hua, Jeremy C. Horn, Jad BouAyache, Rahul Patel, Marcelo Facciuto, Myron Schwartz, Sander Florman, Edward Kim, Ganesh Gunasekaran. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience. Journal of Vascular and Interventional Radiology 2018; 29(7): 920 doi: 10.1016/j.jvir.2018.01.780
|
| 23 |
Mohamedraed Elshami, Fasih A. Ahmed, Hanna Kakish, Jonathan J. Hue, Richard S. Hoehn, Luke D. Rothermel, David Bajor, Amr Mohamed, Jennifer E. Selfridge, John B. Ammori, Jeffrey M. Hardacre, Jordan M. Winter, Lee M. Ocuin. Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancers. HPB 2023; 25(2): 239 doi: 10.1016/j.hpb.2022.11.003
|
| 24 |
Jian Zheng, Deborah Kuk, Mithat Gönen, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, William R. Jarnagin, Ronald P. DeMatteo. Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 2017; 24(5): 1358 doi: 10.1245/s10434-016-5713-2
|
| 25 |
Adeel S. Khan, Kathryn Fowler, William C. Chapman. Optimizing Outcomes for Liver and Pancreas Surgery. 2018; : 63 doi: 10.1007/978-3-319-62624-6_4
|
| 26 |
Prasad WAGLE, Rajvilas NARKHEDE, Gunjan DESAI, Prasad PANDE, D R KULKARNI, Paresh VARTY. SURGICAL MANAGEMENT OF LARGE HEPATOCELLULAR CARCINOMA: THE FIRST SINGLE-CENTER STUDY FROM WESTERN INDIA. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2020; 33(2) doi: 10.1590/0102-672020190001e1505
|
| 27 |
Shanshan Wang, Jia-Rui Xie, Xuanxuan Zou, Taotao Pan, Qi-Chao Yu, Zhenkun Zhuang, Yu Zhong, Zi-Fei Wang, Rui Li, Ying Lei, Jianhua Yin, Yue Yuan, Xiaoyu Wei, Longqi Liu, Shiping Liu, Huanming Yang, Liang Wu. Single-Cell Multiomics Analysis Reveals Heterogeneous Cell States Linked to Metastatic Potential in Liver Cancer Cell Lines. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3904960
|
| 28 |
Hangwei Fu, Rui Dong, Yida Zhang, Jianhua Xu, Menggang Liu, Ping Chen. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation. Cellular Signalling 2019; 55: 65 doi: 10.1016/j.cellsig.2018.12.013
|